MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
General Atlantic
Attachments
Home – General Atlantic
Parents
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Venture Capital & Angel Investors: New York
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
Children
2019: The series B round was led by PathAI’s new backer General Atlantic, alongside participation from General Catalyst
2020: Chi-Med Announces US$100 Million Equity Investment by General Atlantic_ globenewswire
2020: General Atlantic led the Series B round with CCB International, JDRF T1D Fund, Rock Springs Capital, and Eli Lilly
2020: The new funding comes from San Diego-based Illumina, which is supplying the sequencing technology, and previous Ginkgo investors General Atlantic and Viking Global Investors.
2021: Company Founded by Medicxi with Financing Led by General Atlantic, and Co-led by Vida Ventures and Janus Henderson Investors
Centessa Pharmaceuticals plc (NASDAQ: CNTA)*
Closed a $108 million investment round led by General Atlantic.
General Atlantic is an American growth equity firm providing capital and strategic support for global growth companies.
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)*
Hutchison China MediTech, or Chi-Med
Immunocore Holdings plc (NASDAQ: IMCR)*
Mu Sigma
Mu Sigma Closes $108 Million Investment Round, Led by Global Growth Investor General Atlantic (2011)
New York City, New York
PathAI
Subbu Nambi, Director, General Atlantic (2021)